Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 31 -40 of 214 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 12/1/1997


31.		Phase III Extended vs Involved Field Radiotherapy with or without MOPP Chemotherapy for Childhood Hodgkin's Disease (Summary Last Modified 12/97 km)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				under 18				NCI				CCG-541 CLB-7691, POG-7660


32.		Phase III Combination Chemotherapy and Hormone Therapy with NM/VCR/PCB/PRED plus Radiotherapy for Stage III Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MDAR-37


33.		Phase III Radiotherapy plus MOPP (NM/VCR/PCB/PRED) and ABVD (ADR/BLEO/VBL/DTIC) for Stage I/II Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MDA-RT-8001


34.		Phase III Combination Chemotherapy with ADR, CTX, VCR, CACP, VP-16, CCNU, PCB, MTX plus Radiotherapy with/without Thymosin for Limited and Extensive Small Cell Carcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MSKCC-7891R


35.		Phase III Evaluation of MOPP Chemotherapy in the Treatment of Localized Medulloblastoma or Ependynoma in Children (Grade I/II/III/IV) (Summary last modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				1 to 21				NCI				POG-7909 POG-7909

Last Modified: 6/18/2007


36.		Phase III Radiotherapy with or without VCR/CCNU/PCB/PRED Chemotherapy for Medulloblastomas and Ependymomas in Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				2 to 16				NCI				CCG-942 RTOG-7502


37.		Phase III Study of Radiotherapy with vs without Chemotherapy with VCR/CCNU/PRED and PCB for Childhood Astrocytoma (Summary last modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				2 to 21				NCI				CCG-943


38.		Phase III Chemotherapy for Stage III/IV non-Hodgkin's Lymphomas with ProMACE (CTX/ADR/VP-16/PRED/MTX) and MOPP (NM/VCR/PCB/PRED)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				under 65								NCI-78-C-34 NCI-MB-93

Last Modified: 6/1/1997


39.		Phase III Combination Chemotherapy with VCR/CCNU/PRED vs PCB & Radiotherapy for Brain Stem Tumors in Children (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				2 to 21				NCI				CCG-944


40.		Phase III Study of Radiotherapy plus HU/BCNU vs HU/PCB/CCNU/VCR for Primary Malignant Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 and over								NCOG-6G61

Select All on One Page


					< Previous 1 2 3 4 5 6 7 Next >

| | | | | | | |

A Service of the National Cancer Institute